Is a placenta present in a blighted ovum (anembryonic pregnancy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is There a Placenta with Blighted Ovum?

Yes, a placenta (chorionic tissue) is present in a blighted ovum (anembryonic pregnancy), though it develops abnormally without an embryo. 1, 2

Understanding Anembryonic Pregnancy Structure

An anembryonic pregnancy—the preferred modern term over "blighted ovum"—consists of a gestational sac with surrounding trophoblastic tissue (early placental tissue) but no embryo. 3, 1 The key anatomical components include:

  • Gestational sac: A fluid-filled structure measuring ≥25 mm in diameter without an embryo 3, 1
  • Trophoblastic reaction: The placental precursor tissue that forms around the gestational sac, which can appear well-defined and continuous on ultrasound 4
  • Chorionic tissue: This represents the early placental material that develops even in the absence of an embryo 2

Clinical and Pathological Evidence

The presence of placental/chorionic tissue in anembryonic pregnancies is confirmed through multiple lines of evidence:

  • Histopathologic examination of evacuated tissue from anembryonic pregnancies reveals placental villi and chorionic tissue in approximately 50% of cases that meet ultrasound criteria for blighted ovum 5
  • Hormonal production continues from the trophoblastic tissue, with variable but often normal levels of β-hCG, progesterone, and estradiol, demonstrating functional placental tissue despite embryonic absence 5
  • Ultrasound findings show a trophoblastic reaction surrounding the gestational sac, which represents developing placental tissue 4

Important Clinical Distinctions

When managing anembryonic pregnancies, recognize these critical points:

  • Differentiation from complete molar pregnancy: Early complete moles (before 12 weeks) can sometimes mimic anembryonic pregnancy, but molar pregnancies show characteristic hyperechoic areas with multiple cystic spaces rather than a simple empty sac 3, 6
  • Retained products of conception: Following spontaneous or induced passage of an anembryonic pregnancy, residual chorionic/placental tissue may remain, appearing as intracavitary vascularized tissue on Doppler ultrasound 3
  • Genetic implications: Anembryonic pregnancies frequently result from chromosomal errors (50-60% of cases), the same mechanism underlying other early pregnancy losses, and recurrent anembryonic pregnancies may indicate specific genetic mutations (NLRP7, KHDC3L genes) 7

Management Implications

The presence of placental tissue in anembryonic pregnancy has direct clinical relevance:

  • Histopathologic confirmation is recommended after evacuation to confirm intrauterine pregnancy and rule out gestational trophoblastic disease 1
  • Rh immunoprophylaxis is required for all Rh-negative women (50 μg anti-D immunoglobulin) because fetomaternal hemorrhage occurs in 32% of spontaneous abortions, even without an embryo present 2
  • Active management (medical or surgical) is preferred over expectant management due to risks of infection, hemorrhage, and coagulopathy from retained chorionic tissue 1, 2

References

Guideline

Management of Anembryonic Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Aborto: Etiología, Clasificación, Características Clínicas, Diagnóstico y Tratamiento

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sonographic differentiation between blighted ovum and early viable pregnancy.

AJR. American journal of roentgenology, 1985

Research

Blighted ovum: ultrasonic, histopathologic and hormonal considerations.

Clinical and experimental obstetrics & gynecology, 1992

Guideline

Management of Recurrent Pregnancy Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.